Dai, H., Wu, D., Chen, S., Wang, Y. (2025). Phase 1/2, multi-center, open-label clinical study to evaluate the safety, pharmacokinetics, and efficacy of Zefamenib combined with chemotherapy or targeted Agents in patients with Acute Myeloid Leukemia. Blood. https://doi.org/10.1182/blood-2025-8257